COM(2009)709 EU - Report
Report Pursuant to Regulation 273/2004 and to Article 32 of Council Regulation (EC) No 111/2005 on the implementation and functioning of the EC legislation on monitoring and control of trade in drug precursors - Main contents
Please note
This page contains a limited version of this dossier in the Parlementaire Monitor.
official title
Report from the Commission to the Council and the European Parliament Pursuant to Article 16 of Regulation (EC) No 273/2004 of the European Parliament and of the Council of 11 February 2004 and to Article 32 of Council Regulation (EC) No 111/2005 on the implementation and functioning of the Community legislation on monitoring and control of trade in drug precursors| Legal instrument | Report |
|---|---|
| reference by COM-number i | COM(2009)709  |
| Additional COM-numbers | COM(2009)709 |
| CELEX number i | 52009DC0709 |
| Document | 07-01-2010 |
|---|---|
| Online publication | 07-01-2010 |
This page is also available in a full version containing the latest state of affairs, the summary of the European Parliament Legislative Observatory, the legal context, other dossiers related to the dossier at hand, the stakeholders involved (e.g. European Commission directorates-general, European Parliament committees, Council configurations and even individual EU Commissioners and Members of the European Parliament) and finally documents of the European Parliament, the Council of Ministers and the European Commission.
The full version is available for registered users of the EU Monitor by ANP and PDC Informatie Architectuur.
The EU Monitor enables its users to keep track of the European process of lawmaking, focusing on the relevant dossiers. It automatically signals developments in your chosen topics of interest. Apologies to unregistered users, we can no longer add new users.This service will discontinue in the near future.